Stifel Financial Corp Boosts Position in Stryker Corporation (SYK)
Stifel Financial Corp boosted its stake in Stryker Corporation (NYSE:SYK) by 13.7% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 131,253 shares of the medical technology company’s stock after purchasing an additional 15,801 shares during the period. Stifel Financial Corp’s holdings in Stryker Corporation were worth $18,235,000 at the end of the most recent quarter.
A number of other institutional investors also recently bought and sold shares of SYK. Acrospire Investment Management LLC acquired a new stake in Stryker Corporation in the 2nd quarter valued at approximately $111,000. Bollard Group LLC increased its holdings in Stryker Corporation by 0.4% in the 2nd quarter. Bollard Group LLC now owns 832 shares of the medical technology company’s stock valued at $115,000 after purchasing an additional 3 shares during the last quarter. Motco increased its holdings in Stryker Corporation by 50.7% in the 2nd quarter. Motco now owns 826 shares of the medical technology company’s stock valued at $115,000 after purchasing an additional 278 shares during the last quarter. Bruderman Asset Management LLC acquired a new stake in Stryker Corporation in the 2nd quarter valued at approximately $150,000. Finally, James Investment Research Inc. acquired a new stake in Stryker Corporation in the 2nd quarter valued at approximately $155,000. Hedge funds and other institutional investors own 74.10% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: This story was published by Daily Political and is the sole property of of Daily Political. If you are accessing this story on another publication, it was copied illegally and reposted in violation of US and international copyright and trademark law. The correct version of this story can be accessed at https://www.dailypolitical.com/2017/10/16/stifel-financial-corp-boosts-position-in-stryker-corporation-syk.html.
In other Stryker Corporation news, insider Graham A. Mclean sold 1,124 shares of the firm’s stock in a transaction on Tuesday, August 8th. The shares were sold at an average price of $146.26, for a total transaction of $164,396.24. Following the completion of the transaction, the insider now directly owns 8,983 shares of the company’s stock, valued at approximately $1,313,853.58. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Lonny J. Carpenter sold 5,000 shares of the firm’s stock in a transaction on Friday, August 4th. The stock was sold at an average price of $146.36, for a total transaction of $731,800.00. Following the transaction, the insider now directly owns 88,207 shares of the company’s stock, valued at $12,909,976.52. The disclosure for this sale can be found here. 7.40% of the stock is currently owned by company insiders.
SYK has been the subject of several research reports. Zacks Investment Research upgraded shares of Stryker Corporation from a “hold” rating to a “buy” rating and set a $163.00 price target for the company in a research note on Monday, July 17th. Cowen and Company restated a “buy” rating and issued a $160.00 price target (up previously from $150.00) on shares of Stryker Corporation in a research note on Sunday, July 30th. Stifel Nicolaus boosted their price target on shares of Stryker Corporation from $151.00 to $158.00 and gave the stock a “buy” rating in a research note on Friday, July 28th. BidaskClub upgraded shares of Stryker Corporation from a “hold” rating to a “buy” rating in a research note on Thursday, August 17th. Finally, Canaccord Genuity restated a “buy” rating and issued a $155.00 price target (down previously from $158.00) on shares of Stryker Corporation in a research note on Thursday, August 24th. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and twelve have given a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $146.78.
Shares of Stryker Corporation (NYSE:SYK) opened at 146.69 on Monday. The company has a 50-day moving average of $143.05 and a 200-day moving average of $140.60. Stryker Corporation has a 12 month low of $106.48 and a 12 month high of $149.23. The stock has a market capitalization of $54.87 billion, a PE ratio of 32.74 and a beta of 0.81.
Stryker Corporation (NYSE:SYK) last released its quarterly earnings results on Thursday, July 27th. The medical technology company reported $1.53 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.51 by $0.02. The business had revenue of $3.01 billion during the quarter, compared to analyst estimates of $2.98 billion. Stryker Corporation had a net margin of 14.22% and a return on equity of 24.26%. The business’s revenue was up 6.1% on a year-over-year basis. During the same period last year, the business earned $1.39 EPS. On average, equities research analysts expect that Stryker Corporation will post $6.45 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, October 31st. Investors of record on Friday, September 29th will be issued a dividend of $0.425 per share. This represents a $1.70 dividend on an annualized basis and a yield of 1.16%. The ex-dividend date is Thursday, September 28th. Stryker Corporation’s payout ratio is 37.95%.
About Stryker Corporation
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).
Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.